CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-16 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −872 | 0 | ||
| 2025-03-16 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +994 | 23,848 | ||
| 2025-03-16 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −292 | $22.61 | $7K | 23,556 |
| 2025-03-16 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Share Unit | −994 | 0 | ||
| 2025-03-16 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +774 | 27,771 | ||
| 2025-03-16 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −328 | $22.61 | $7K | 27,443 |
| 2025-03-16 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −774 | 0 | ||
| 2025-03-16 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +1,964 | 78,530 | ||
| 2025-03-16 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −577 | $22.61 | $13K | 77,953 |
| 2025-03-16 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −1,964 | 0 | ||
| 2025-03-16 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +6,569 | 86,120 | ||
| 2025-03-16 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −2,004 | $22.61 | $45K | 84,116 |
| 2025-03-16 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,569 | 0 | ||
| 2025-03-16 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +1,725 | 53,763 | ||
| 2025-03-16 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −507 | $22.61 | $11K | 53,256 |
| 2025-03-16 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −1,725 | 0 | ||
| 2025-03-12 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +9,051 | $11.10 | $100K | 35,579 |
| 2025-03-12 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −9,051 | $22.45 | $203K | 26,528 |
| 2025-03-12 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −9,051 | 13,763 | ||
| 2025-03-12 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +36,372 | $11.97 | $435K | 59,330 |
Page 42 of 74 · 1,467 trades